Quantcast
Channel: New-York – EEI-BIOTECHFINANCES
Browsing all 1030 articles
Browse latest View live

Image may be NSFW.
Clik here to view.

Eagle Pharmaceuticals Announces “Save the Date” for 2016 Investor Day

Tuesday, September 27th 2016 at 8:30pm UTC WOODCLIFF LAKE, N.J.–(BUSINESS WIRE)– Eagle Pharmaceuticals, Inc. (“Eagle” or “the Company”) (NASDAQ:EGRX) today announced that Scott Tarriff, President and...

View Article


Image may be NSFW.
Clik here to view.

NYSCF Calls For Faster FDA Review to Curb Stem Cell Tourism Citing Baby Born...

Wednesday, September 28th 2016 at 5:56pm UTC NEW YORK–(BUSINESS WIRE)– A report in The New Scientist presents claims that the first baby was born in Mexico by a New York based doctor using...

View Article


Image may be NSFW.
Clik here to view.

Pfizer Completes Acquisition of Medivation

Wednesday, September 28th 2016 at 12:50pm UTC Tender offer for all of the outstanding shares of Medivation common stock expired as scheduled one minute after 11:59 p.m., Eastern time, on September 27,...

View Article

Image may be NSFW.
Clik here to view.

Delcath Prices Underwritten Public Offering of Common Stock and Warrants

Friday, September 30th 2016 at 1:22pm UTC NEW YORK–(BUSINESS WIRE)– Delcath Systems, Inc. (DCTH) (the « Company »), an interventional oncology company focused on treatments for primary and metastatic...

View Article

Image may be NSFW.
Clik here to view.

Hot Topics Recap: Breast Cancer Awareness Month 2016

Friday, September 30th 2016 at 1:08pm UTC NEW YORK–(BUSINESS WIRE)– Following are the latest Breast Cancer Awareness Month 2016 news releases and story ideas for reporters, bloggers and media outlets:...

View Article


Image may be NSFW.
Clik here to view.

Acorda Announces Departure of Michael Rogers

Tuesday, October 4th 2016 at 10:00am UTC ARDSLEY, N.Y.–(BUSINESS WIRE)– Acorda Therapeutics, Inc. (Nasdaq:ACOR) today announced that Chief Financial Officer Michael Rogers has left the company. David...

View Article

Image may be NSFW.
Clik here to view.

Pharnext soutient la première conférence dédiée aux patients atteints de la...

Tuesday, October 4th 2016 at 6:00am UTC Cette conférence réunira des patients, du personnel soignant, des industriels, des chercheurs et des cliniciens PARIS–(BUSINESS WIRE)– Regulatory News: Pharnext...

View Article

Image may be NSFW.
Clik here to view.

Pharnext Announces Support of the First Patient-Centered Charcot-Marie-Tooth...

Tuesday, October 4th 2016 at 6:00am UTC The summit will bring together patients, caregivers, top industry leaders, researchers and clinicians PARIS–(BUSINESS WIRE)– Regulatory News: Pharnext...

View Article


Image may be NSFW.
Clik here to view.

PixarBio Corporation CEO Frank Reynolds to Receive The 2016 Irish America...

Tuesday, October 4th 2016 at 10:00am UTC CAMBRIDGE, Mass.–(BUSINESS WIRE)– Today announced that Frank Reynolds Co-founder and CEO of PixarBio Corporation, and inventors of NeuroReleaseTM, a novel...

View Article


Image may be NSFW.
Clik here to view.

Replicor divulgará los últimos datos clínicos sobre el VHB en la AASLD 2016

Tuesday, October 4th 2016 at 12:00pm UTC NUEVA YORK–(BUSINESS WIRE)– Replicor Inc., una empresa biofarmacéutica de capital privado enfocada en encontrar una cura para los pacientes con hepatitis B y D...

View Article

Image may be NSFW.
Clik here to view.

22nd Century Announces Expiration of 2,250,000 Crede Warrants

Tuesday, October 4th 2016 at 1:55pm UTC Aggregate of 4,250,000 shares of potential dilution from the Crede warrants will be avoided entirely CLARENCE, N.Y.–(BUSINESS WIRE)– 22nd Century Group, Inc....

View Article

Image may be NSFW.
Clik here to view.

Replicor to Disclose Late Breaking HBV Clinical Data at AASLD 2016

Tuesday, October 4th 2016 at 12:00pm UTC NEW YORK–(BUSINESS WIRE)– Replicor Inc., a privately held biopharmaceutical company targeting a cure for chronic hepatitis B and D patients, today announced...

View Article

Image may be NSFW.
Clik here to view.

Replicor dévoilera les dernières données cliniques sur le VHB à l’AASLD 2016

Tuesday, October 4th 2016 at 12:00pm UTC NEW YORK–(BUSINESS WIRE)– Replicor Inc., une société biopharmaceutique privée ciblant un traitement pour l’hépatite B et D chronique, a annoncé aujourd’hui que...

View Article


Image may be NSFW.
Clik here to view.

Siemens Receives FDA Clearance of the Xprecia Stride™ Coagulation Analyzer

Tuesday, October 4th 2016 at 6:43pm UTC The Xprecia Stride is a truly handheld portable analyzer for any professional point-of-care setting Features such as an integrated bar-code scanner, hands-free...

View Article

Image may be NSFW.
Clik here to view.

Pall Life Sciences Extends the Range of Continuous, Single-Use Technologies...

Tuesday, October 4th 2016 at 1:09pm UTC PORT WASHINGTON, N.Y.–(BUSINESS WIRE)– Pall Corporation, a global leader in filtration, separation and purification, is pleased to announce the launch of...

View Article


Image may be NSFW.
Clik here to view.

TELOYEARS™—A New Genetic Test that Reveals the Cellular Age Encoded in One’s...

Wednesday, October 5th 2016 at 11:30am UTC Test lets you discover how well you’re aging based on your telomeres MENLO PARK, Calif.–(BUSINESS WIRE)– Today marks the launch of TeloYears, a new genetic...

View Article

Image may be NSFW.
Clik here to view.

Pall Corporation and RoosterBio, Inc. Announce Collaboration Agreement to...

Wednesday, October 5th 2016 at 1:00pm UTC PORT WASHINGTON, N.Y.–(BUSINESS WIRE)– Pall Corporation, a global leader in bioprocess equipment and disposables, announced the signing of a commercial...

View Article


Image may be NSFW.
Clik here to view.

Cellectis Announces the Issuance of U.S. Patent 9,458,439 Following U.S....

Tuesday, October 4th 2016 at 9:00pm UTC Two Patents of a Family Claiming the Basic Uses of Chimeric Restriction Nucleases for Gene Editing in Any Type of Cells NEW YORK–(BUSINESS WIRE)– Regulatory...

View Article

Image may be NSFW.
Clik here to view.

Even Don Wright Admits He Didn’t Think He Could Reach His Goal, But MY LIFE...

Thursday, October 6th 2016 at 11:02am UTC –Scheduled to Run the Des Moines Marathon, His 99th, on Oct. 16th — –And His Milestone 100th at the Philadelphia Marathon on Nov. 20th — –Don was Diagnosed...

View Article

Image may be NSFW.
Clik here to view.

Phase III Clinical Trial with 22nd Century’s Very Low Nicotine Cigarettes...

Thursday, October 6th 2016 at 4:12pm UTC CLARENCE, N.Y.–(BUSINESS WIRE)– 22nd Century Group, Inc. (NYSE MKT: XXII), a plant biotechnology company that is a leader in tobacco harm reduction, announced...

View Article
Browsing all 1030 articles
Browse latest View live